RMD Filing
4Filing Date: Mar 5, 2026
RESMED INC (RMD) · Insider Trading (Form 4) SEC Filing
Statement of Changes in Beneficial Ownership
descriptionView SEC Filing
ACC: 0000943819-26-000014open_in_new
Total Value$520.4K
Trades1
Insiders1
Transaction Details
FARRELL PETER C
Director·Direct
Sell · Dispose
ResMed Common Stock
Shares-2.00K
Price$260.22
Total Value$520.4K
Shares Owned After62.77K
Transaction DateMar 4, 2026
10b5-1
Footnotes ▸
The transaction was conducted under a Rule 10b5-1 plan adopted August 12, 2025.
Post-Transaction Holdings
FARRELL PETER C
| Security | Shares | Change |
|---|---|---|
| ResMed Common Stock | 62.77K | -2.00K (-3.09%) |
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-03-04
10b5-1 Pre-arranged Plan: Yes
--- Issuer ---
Name: RESMED INC (RMD)
CIK: 0000943819
--- Reporting Owner ---
Name: FARRELL PETER C
CIK: 0001186102
Role: Director
--- Non-Derivative Transactions ---
[Transaction #1]
Security: ResMed Common Stock
Date: 2026-03-04 | Code: S (Open market sale)
Shares: -2,000 | Price: $260.22
Total Value: $520,440.00
Shares Owned After: 62,773 | Ownership: D (Direct)
Footnotes:
[F1] The transaction was conducted under a Rule 10b5-1 plan adopted August 12, 2025.
--- Footnotes (Complete Index) ---
F1: The transaction was conducted under a Rule 10b5-1 plan adopted August 12, 2025.
--- Signature ---
/s/ /s/ Peter C. Farrell, Chairman emeritus (2026-03-05)